Required information [The following information applies to the questions displayed below.] The December 31, 2021, unadjusted trial balance for the Wolkstein Drug Company is presented below. December 31 is the company's year-end reporting date. Account Title Cash Accounts receivable Debits 37,410 Credits 34,250 Prepaid rent 5,800 Inventory 53,750 Equipment 126,000 Accumulated depreciation Accounts payable 37,800 39,000 Salaries payable 0 Common stock Retained earnings Sales revenue 100,000 38,500 523,000 Cost of goods sold 313,800 Salaries expense 104,600 Rent expense 34,800 Depreciation expense 0 Utilities expense 20,920 Advertising expense 6,970 Totals 738,300 738,300 The following year-end adjusting entries are required: a. Depreciation expense for the year on the equipment is $12,600. b. Salaries at year-end should be accrued in the amount of $6,680. 2. Prepare an income statement for 2021 and a balance sheet as of December 31, 2021